Loading clinical trials...
Loading clinical trials...
Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating an Intensified Enteric-coated Mycophenolate Sodium (EC-MPS) Dosing Regimen in Comparison to a Standard Dosing Regimen of EC-MPS in Combination With Cyclosporin Microemulsion and Corticosteroids in de Novo Renal Transplant Patients
Conditions
Interventions
Enteric-coated mycophenolate sodium (EC-MPS)
Locations
1
Germany
Novartis Investigational Site
Various Cities, Germany
Start Date
June 1, 2006
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2008
Last Updated
March 29, 2011
NCT07294183
NCT05086003
NCT03478215
NCT03504241
NCT04774575
NCT05208788
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions